WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: RAYLUMIS

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on RAYLUMIS

Proof of use for RAYLUMIS

We do not have any records of a proof of use for RAYLUMIS at this moment.

Click here to add a proof of use for RAYLUMIS

Possible trademark infringements of RAYLUMIS

Basic Information about RAYLUMIS

Serial Number
87492521
Filing Date
16 Jun 2017
Registration Number
6180502
Registration Date
20 Oct 2020
Mark Drawing Code
4

Classifications

Declare the trademark use of RAYLUMIS on the blockchain with WikiTrademarks.io.

First use of RAYLUMIS anywhere
RAYLUMIS was first used on 01 Jul 2020 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns RAYLUMIS?

1. Pfizer Inc. New York NY

2. Pfizer Inc. New York NY

3. Pfizer Inc. New York NY

Correspondent

Andrea Christensen
PFIZER INC.
66 Hudson Boulevard East
NEW YORK NY 10001-2192

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on RAYLUMIS